0 XP   0   0   0

Granules India Limited
Buy, Hold or Sell?

Should you buy, hold or sell Granules India Limited?

I guess you are interested in Granules India Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Granules India Limited

Let's start. I'm going to help you getting a better view of Granules India Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Granules India Limited even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Granules India Limited is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Granules India Limited. The closing price on 2023-01-27 was INR284.10 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Granules India Limited Daily Candlestick Chart
Granules India Limited Daily Candlestick Chart
Summary









1. Valuation of Granules India Limited




Current price per share

INR284.10

2. Growth of Granules India Limited




Is Granules India Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$318.1m$267.3m$50.8m16.0%

How much money is Granules India Limited making?

Current yearPrevious yearGrowGrow %
Making money$50.7m$67.5m-$16.8m-33.1%
Net Profit Margin11.0%17.0%--

How much money comes from the company's main activities?

3. Financial Health of Granules India Limited




Comparing to competitors in the Drug Manufacturers - Major industry




  Industry Rankings (Drug Manufacturers - Major)  



Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Granules India Limited.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Granules India Limited earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Granules India Limited to the Drug Manufacturers - Major industry mean.
  • A Net Profit Margin of 11.0% means that ₹0.11 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Granules India Limited:

  • The MRQ is 11.0%. The company is making a huge profit. +2
  • The TTM is 11.0%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ11.0%TTM11.0%0.0%
TTM11.0%YOY17.0%-6.0%
TTM11.0%5Y11.8%-0.8%
5Y11.8%10Y10.4%+1.4%
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ11.0%10.8%+0.2%
TTM11.0%10.8%+0.2%
YOY17.0%14.8%+2.2%
5Y11.8%12.2%-0.4%
10Y10.4%11.9%-1.5%
1.1.2. Return on Assets

Shows how efficient Granules India Limited is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Granules India Limited to the Drug Manufacturers - Major industry mean.
  • 9.1% Return on Assets means that Granules India Limited generated ₹0.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Granules India Limited:

  • The MRQ is 9.1%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 9.1%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ9.1%TTM9.1%0.0%
TTM9.1%YOY14.8%-5.7%
TTM9.1%5Y9.4%-0.3%
5Y9.4%10Y8.8%+0.7%
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ9.1%1.8%+7.3%
TTM9.1%2.3%+6.8%
YOY14.8%3.0%+11.8%
5Y9.4%3.0%+6.4%
10Y8.8%2.7%+6.1%
1.1.3. Return on Equity

Shows how efficient Granules India Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Granules India Limited to the Drug Manufacturers - Major industry mean.
  • 16.0% Return on Equity means Granules India Limited generated ₹0.16 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Granules India Limited:

  • The MRQ is 16.0%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 16.0%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ16.0%TTM16.0%0.0%
TTM16.0%YOY25.3%-9.3%
TTM16.0%5Y17.0%-1.1%
5Y17.0%10Y18.2%-1.2%
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ16.0%2.5%+13.5%
TTM16.0%3.9%+12.1%
YOY25.3%4.4%+20.9%
5Y17.0%4.2%+12.8%
10Y18.2%4.0%+14.2%

1.2. Operating Efficiency of Granules India Limited.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Granules India Limited is operating .

  • Measures how much profit Granules India Limited makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Granules India Limited to the Drug Manufacturers - Major industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Granules India Limited:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y12.2%-12.2%
5Y12.2%10Y13.0%-0.8%
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ-29.7%-29.7%
TTM-11.5%-11.5%
YOY-11.7%-11.7%
5Y12.2%12.0%+0.2%
10Y13.0%11.0%+2.0%
1.2.2. Operating Ratio

Measures how efficient Granules India Limited is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Major industry mean).
  • An Operation Ratio of 0.51 means that the operating costs are ₹0.51 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Granules India Limited:

  • The MRQ is 0.514. The company is very efficient in keeping operating costs low. +2
  • The TTM is 0.514. The company is very efficient in keeping operating costs low. +2
Trends
Current periodCompared to+/- 
MRQ0.514TTM0.5140.000
TTM0.514YOY0.442+0.072
TTM0.5145Y1.030-0.516
5Y1.03010Y1.206-0.176
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5140.475+0.039
TTM0.5140.425+0.089
YOY0.4420.731-0.289
5Y1.0300.943+0.087
10Y1.2060.983+0.223

1.3. Liquidity of Granules India Limited.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Granules India Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Major industry mean).
  • A Current Ratio of 1.53 means the company has ₹1.53 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Granules India Limited:

  • The MRQ is 1.526. The company is able to pay all its short-term debts. +1
  • The TTM is 1.526. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.526TTM1.5260.000
TTM1.526YOY1.702-0.176
TTM1.5265Y1.567-0.041
5Y1.56710Y1.403+0.163
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5261.824-0.298
TTM1.5261.800-0.274
YOY1.7021.807-0.105
5Y1.5671.305+0.262
10Y1.4031.218+0.185
1.3.2. Quick Ratio

Measures if Granules India Limited is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Granules India Limited to the Drug Manufacturers - Major industry mean.
  • A Quick Ratio of 0.87 means the company can pay off ₹0.87 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Granules India Limited:

  • The MRQ is 0.870. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.870. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.870TTM0.8700.000
TTM0.870YOY1.065-0.195
TTM0.8705Y0.937-0.067
5Y0.93710Y0.773+0.164
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8701.248-0.378
TTM0.8701.200-0.330
YOY1.0651.151-0.086
5Y0.9370.836+0.101
10Y0.7730.750+0.023

1.4. Solvency of Granules India Limited.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Granules India Limited assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Granules India Limited to Drug Manufacturers - Major industry mean.
  • A Debt to Asset Ratio of 0.43 means that Granules India Limited assets are financed with 42.7% credit (debt) and the remaining percentage (100% - 42.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Granules India Limited:

  • The MRQ is 0.427. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.427. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.427TTM0.4270.000
TTM0.427YOY0.415+0.012
TTM0.4275Y0.454-0.027
5Y0.45410Y0.517-0.062
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4270.415+0.012
TTM0.4270.419+0.008
YOY0.4150.429-0.014
5Y0.4540.455-0.001
10Y0.5170.431+0.086
1.4.2. Debt to Equity Ratio

Measures if Granules India Limited is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Granules India Limited to the Drug Manufacturers - Major industry mean.
  • A Debt to Equity ratio of 74.5% means that company has ₹0.74 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Granules India Limited:

  • The MRQ is 0.745. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.745. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.745TTM0.7450.000
TTM0.745YOY0.709+0.036
TTM0.7455Y0.841-0.097
5Y0.84110Y1.136-0.295
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7450.675+0.070
TTM0.7450.698+0.047
YOY0.7090.738-0.029
5Y0.8410.840+0.001
10Y1.1360.814+0.322

2. Market Valuation of Granules India Limited

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Granules India Limited generates.

  • Above 15 is considered overpriced but always compare Granules India Limited to the Drug Manufacturers - Major industry mean.
  • A PE ratio of 18.40 means the investor is paying ₹18.40 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Granules India Limited:

  • The EOD is 17.070. Very good. +2
  • The MRQ is 18.404. Very good. +2
  • The TTM is 18.404. Very good. +2
Trends
Current periodCompared to+/- 
EOD17.070MRQ18.404-1.334
MRQ18.404TTM18.4040.000
TTM18.404YOY13.672+4.732
TTM18.4045Y15.014+3.390
5Y15.01410Y25.265-10.251
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
EOD17.07073.229-56.159
MRQ18.40466.328-47.924
TTM18.40460.797-42.393
YOY13.67233.289-19.617
5Y15.01460.412-45.398
10Y25.26564.422-39.157
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Granules India Limited.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Granules India Limited:

  • The MRQ is 24.532. Seems overpriced? -1
  • The TTM is 24.532. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ24.532TTM24.5320.000
TTM24.532YOY8.130+16.402
TTM24.5325Y14.488+10.044
5Y14.48810Y15.629-1.141
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ24.532-0.235+24.767
TTM24.5320.137+24.395
YOY8.1300.124+8.006
5Y14.4880.232+14.256
10Y15.6290.222+15.407

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Granules India Limited is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Major industry mean).
  • A PB ratio of 2.94 means the investor is paying ₹2.94 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Granules India Limited:

  • The EOD is 2.724. Good. +1
  • The MRQ is 2.937. Good. +1
  • The TTM is 2.937. Good. +1
Trends
Current periodCompared to+/- 
EOD2.724MRQ2.937-0.213
MRQ2.937TTM2.9370.000
TTM2.937YOY3.457-0.520
TTM2.9375Y2.458+0.479
5Y2.45810Y4.805-2.347
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
EOD2.7241.495+1.229
MRQ2.9371.439+1.498
TTM2.9371.890+1.047
YOY3.4572.460+0.997
5Y2.4581.972+0.486
10Y4.8052.221+2.584
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Granules India Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--16.54616.5460%15.230+9%13.561+22%11.588+43%
Book Value Growth--1.1901.1900%1.179+1%1.238-4%1.288-8%
Book Value Per Share--104.293104.2930%87.747+19%75.218+39%52.342+99%
Book Value Per Share Growth--1.1891.1890%1.210-2%1.237-4%1.287-8%
Current Ratio--1.5261.5260%1.702-10%1.567-3%1.403+9%
Debt To Asset Ratio--0.4270.4270%0.415+3%0.454-6%0.517-17%
Debt To Equity Ratio--0.7450.7450%0.709+5%0.841-11%1.136-34%
Dividend Per Share--1.4991.4990%0.998+50%1.210+24%0.936+60%
Dividend Per Share Growth--1.5021.5020%0.828+81%1.130+33%1.399+7%
Eps--16.64316.6430%22.185-25%13.308+25%9.429+77%
Eps Growth--0.7500.7500%1.682-55%1.283-42%1.289-42%
Free Cash Flow Per Share---2.647-2.6470%6.506-141%-0.591-78%-1.655-37%
Free Cash Flow Per Share Growth---0.407-0.4070%0.567-172%3.945-110%0.863-147%
Free Cash Flow To Equity Per Share--5.0145.0140%-5.579+211%0.878+471%0.538+831%
Free Cash Flow To Equity Per Share Growth--2.8992.8990%-1.799+162%1.611+80%1.799+61%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---138.882--------
Intrinsic Value_10Y_min---115.355--------
Intrinsic Value_1Y_max---5.088--------
Intrinsic Value_1Y_min---4.944--------
Intrinsic Value_3Y_max---22.017--------
Intrinsic Value_3Y_min---20.673--------
Intrinsic Value_5Y_max---47.057--------
Intrinsic Value_5Y_min---42.657--------
Net Profit Margin--0.1100.1100%0.170-35%0.118-7%0.104+6%
Operating Margin----0%-0%0.122-100%0.130-100%
Operating Ratio--0.5140.5140%0.442+16%1.030-50%1.206-57%
Pb Ratio2.724-8%2.9372.9370%3.457-15%2.458+20%4.805-39%
Pe Ratio17.070-8%18.40418.4040%13.672+35%15.014+23%25.265-27%
Peg Ratio--24.53224.5320%8.130+202%14.488+69%15.629+57%
Price Per Share284.100-8%306.300306.3000%303.300+1%194.200+58%174.461+76%
Price To Total Gains Ratio15.744-8%16.97416.9740%18.690-9%12.831+32%14.620+16%
Profit Growth--0.7510.7510%1.638-54%1.279-41%1.287-42%
Quick Ratio--0.8700.8700%1.065-18%0.937-7%0.773+12%
Return On Assets--0.0910.0910%0.148-38%0.094-3%0.088+4%
Return On Equity--0.1600.1600%0.253-37%0.170-6%0.182-12%
Revenue Growth--1.1631.1630%1.246-7%1.215-4%1.170-1%
Total Gains Per Share--18.04518.0450%16.228+11%14.771+22%12.524+44%
Total Gains Per Share Growth--1.1121.1120%1.196-7%1.158-4%1.263-12%
Usd Book Value--318143546.700318143546.7000%267312738.900+19%232154635.380+37%161123184.433+97%
Usd Book Value Change Per Share--0.2040.2040%0.187+9%0.167+22%0.143+43%
Usd Book Value Per Share--1.2831.2830%1.079+19%0.925+39%0.644+99%
Usd Dividend Per Share--0.0180.0180%0.012+50%0.015+24%0.012+60%
Usd Eps--0.2050.2050%0.273-25%0.164+25%0.116+77%
Usd Free Cash Flow----0%-0%-0%-0%
Usd Free Cash Flow Per Share---0.033-0.0330%0.080-141%-0.007-78%-0.020-37%
Usd Free Cash Flow To Equity Per Share--0.0620.0620%-0.069+211%0.011+471%0.007+831%
Usd Price Per Share3.494-8%3.7673.7670%3.731+1%2.389+58%2.146+76%
Usd Profit--50769221.70050769221.7000%67583457.000-25%40998726.540+24%28977072.533+75%
Usd Revenue--463085283.000463085283.0000%398217764.400+16%333875044.980+39%256678633.133+80%
Usd Total Gains Per Share--0.2220.2220%0.200+11%0.182+22%0.154+44%
 EOD+3 -2MRQTTM+0 -0YOY+17 -235Y+22 -1910Y+28 -13

3.2. Fundamental Score

Let's check the fundamental score of Granules India Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1517.070
Price to Book Ratio (EOD)Between0-12.724
Net Profit Margin (MRQ)Greater than00.110
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.870
Current Ratio (MRQ)Greater than11.526
Debt to Asset Ratio (MRQ)Less than10.427
Debt to Equity Ratio (MRQ)Less than10.745
Return on Equity (MRQ)Greater than0.150.160
Return on Assets (MRQ)Greater than0.050.091
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Granules India Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose288.100
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2022-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets45,128,976
Total Liabilities19,263,647
Total Stockholder Equity25,865,329
 As reported
Total Liabilities 19,263,647
Total Stockholder Equity+ 25,865,329
Total Assets = 45,128,976

Assets

Total Assets45,128,976
Total Current Assets25,049,815
Long-term Assets25,049,815
Total Current Assets
Short-term Investments 2,114,380
Net Receivables 9,249,544
Inventory 10,120,555
Other Current Assets 2,289,519
Total Current Assets  (as reported)25,049,815
Total Current Assets  (calculated)23,773,998
+/- 1,275,817
Long-term Assets
Property Plant Equipment 15,956,393
Intangible Assets 3,017,659
Long-term Assets  (as reported)0
Long-term Assets  (calculated)18,974,052
+/- 18,974,052

Liabilities & Shareholders' Equity

Total Current Liabilities16,416,000
Long-term Liabilities-
Total Stockholder Equity25,865,329
Total Current Liabilities
Short-term Debt 7,655,765
Total Current Liabilities  (as reported)16,416,000
Total Current Liabilities  (calculated)7,655,765
+/- 8,760,235
Long-term Liabilities
Long term Debt Total 2,419,818
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)2,419,818
+/- 2,419,818
Total Stockholder Equity
Common Stock248,006
Retained Earnings 20,591,848
Capital Surplus 4,560,409
Other Stockholders Equity 297,855
Total Stockholder Equity (as reported)25,865,329
Total Stockholder Equity (calculated)25,698,118
+/- 167,211
Other
Cash And Equivalents796,093
Cash and Short Term Investments 2,910,473
Common Stock Shares Outstanding 248,006
Liabilities and Stockholders Equity 45,128,976



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-31
> Total Assets 
9,920,134
12,027,115
15,629,722
18,787,186
26,772,267
29,828,132
32,283,571
37,134,504
45,128,976
45,128,97637,134,50432,283,57129,828,13226,772,26718,787,18615,629,72212,027,1159,920,134
   > Total Current Assets 
3,769,215
5,003,587
8,180,015
8,281,641
11,865,657
12,822,417
16,286,981
19,970,017
25,049,815
25,049,81519,970,01716,286,98112,822,41711,865,6578,281,6418,180,0155,003,5873,769,215
       Cash And Cash Equivalents 
417,471
653,066
1,241,957
314,974
830,000
483,761
2,839,427
407,039
0
0407,0392,839,427483,761830,000314,9741,241,957653,066417,471
       Short-term Investments 
0
0
0
24,746
0
0
36,097
2,214,243
2,114,380
2,114,3802,214,24336,0970024,746000
       Net Receivables 
1,274,230
2,023,499
3,753,458
4,177,002
6,282,511
6,735,424
6,620,357
7,654,201
9,249,544
9,249,5447,654,2016,620,3576,735,4246,282,5114,177,0023,753,4582,023,4991,274,230
       Inventory 
1,741,634
2,245,166
2,537,181
2,691,784
3,022,628
4,119,290
4,384,308
8,208,476
10,120,555
10,120,5558,208,4764,384,3084,119,2903,022,6282,691,7842,537,1812,245,1661,741,634
       Other Current Assets 
301,010
37,590
519,057
594,119
994,137
798,260
2,328,027
895,629
2,289,519
2,289,519895,6292,328,027798,260994,137594,119519,05737,590301,010
   > Long-term Assets 
0
0
0
10,413,663
14,906,610
17,005,715
15,996,590
0
0
0015,996,59017,005,71514,906,61010,413,663000
       Property Plant Equipment 
4,992,092
5,900,775
5,536,387
6,989,850
9,908,626
10,710,565
11,368,425
12,559,932
15,956,393
15,956,39312,559,93211,368,42510,710,5659,908,6266,989,8505,536,3875,900,7754,992,092
       Long Term Investments 
1,914
1,914
701,076
1,082,294
0
0
0
0
0
000001,082,294701,0761,9141,914
       Intangible Assets 
1,078,209
885,073
828,545
2,127,808
3,003,831
3,691,431
3,613,358
3,150,842
3,017,659
3,017,6593,150,8423,613,3583,691,4313,003,8312,127,808828,545885,0731,078,209
       Long-term Assets Other 
0
0
0
184,387
224,394
0
597,487
0
0
00597,4870224,394184,387000
> Total Liabilities 
6,360,513
7,715,480
9,013,722
9,751,232
13,730,508
14,533,401
13,846,330
15,401,761
19,263,647
19,263,64715,401,76113,846,33014,533,40113,730,5089,751,2329,013,7227,715,4806,360,513
   > Total Current Liabilities 
2,925,382
4,150,280
6,547,495
7,871,328
8,779,113
8,964,820
8,933,980
11,730,981
16,416,000
16,416,00011,730,9818,933,9808,964,8208,779,1137,871,3286,547,4954,150,2802,925,382
       Short-term Debt 
4,417,284
4,822,289
3,928,542
4,738,330
5,250,995
4,542,061
3,716,909
4,092,705
7,655,765
7,655,7654,092,7053,716,9094,542,0615,250,9954,738,3303,928,5424,822,2894,417,284
       Short Long Term Debt 
4,417,284
4,822,289
6,413,947
6,565,019
5,453,111
5,123,969
3,716,909
0
0
003,716,9095,123,9695,453,1116,565,0196,413,9474,822,2894,417,284
       Accounts payable 
1,355,445
1,876,253
1,810,986
2,159,756
2,743,478
3,234,774
4,300,221
0
0
004,300,2213,234,7742,743,4782,159,7561,810,9861,876,2531,355,445
       Other Current Liabilities 
183,016
367,085
43,149
185,551
389,314
342,552
386,511
0
0
00386,511342,552389,314185,55143,149367,085183,016
   > Long-term Liabilities 
0
0
0
1,879,904
4,951,395
5,568,581
4,912,350
0
0
004,912,3505,568,5814,951,3951,879,904000
       Long term Debt Total 
0
0
1,842,127
1,242,423
4,331,302
4,787,825
4,215,225
3,411,433
2,419,818
2,419,8183,411,4334,215,2254,787,8254,331,3021,242,4231,842,12700
       Deferred Long Term Liability 
35,374
26,666
0
0
0
0
0
0
0
000000026,66635,374
> Total Stockholder Equity
3,559,621
4,311,635
6,616,000
9,035,954
13,041,759
15,294,731
18,437,241
21,732,743
25,865,329
25,865,32921,732,74318,437,24115,294,73113,041,7599,035,9546,616,0004,311,6353,559,621
   Common Stock
202,812
204,252
216,712
228,703
253,838
254,248
254,248
247,675
248,006
248,006247,675254,248254,248253,838228,703216,712204,252202,812
   Retained Earnings 
2,001,087
2,742,175
4,150,342
5,448,857
6,484,270
8,541,962
18,182,993
16,836,549
20,591,848
20,591,84816,836,54918,182,9938,541,9626,484,2705,448,8574,150,3422,742,1752,001,087
   Capital Surplus 
0
0
2,248,946
3,337,639
6,242,909
6,252,054
6,252,054
4,528,635
4,560,409
4,560,4094,528,6356,252,0546,252,0546,242,9093,337,6392,248,94600
   Treasury Stock000000000
   Other Stockholders Equity 
164,918
162,239
315,125
-3,725
6,624
136,867
158,716
-102,889
297,855
297,855-102,889158,716136,8676,624-3,725315,125162,239164,918



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2022-03-31)

Gross Profit (+$)
totalRevenue37,649,210
Cost of Revenue-19,352,371
Gross Profit18,296,83918,296,839
 
Operating Income (+$)
Gross Profit18,296,839
Operating Expense--
Operating Income5,748,93818,296,839
 
Operating Expense (+$)
Research Development-
Selling General Administrative10,815,787
Selling And Marketing Expenses-
Operating Expense-10,815,787
 
Net Interest Income (+$)
Interest Income50,576
Interest Expense--
Net Interest Income-50,576
 
Pretax Income (+$)
Operating Income5,748,938
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)5,579,9835,748,938
EBIT - interestExpense = 0
4,127,579
4,127,579
Interest Expense-
Earnings Before Interest and Taxes (ebit)-5,579,983
Earnings Before Interest and Taxes (ebitda)-
 
After tax Income (+$)
Income Before Tax5,579,983
Tax Provision-1,452,402
Net Income From Continuing Ops-4,127,581
Net Income4,127,579
Net Income Applicable To Common Shares4,127,579
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-0
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
NGU24-NYM.COMM
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NGU24-NYM.COMM.

NGU24-NYM.COMM Daily Candlestick Chart
NGM24-NYM.COMM
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NGM24-NYM.COMM.

NGM24-NYM.COMM Daily Candlestick Chart
NGQ24-NYM.COMM
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NGQ24-NYM.COMM.

NGQ24-NYM.COMM Daily Candlestick Chart
ISKJ.MCX
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ISKJ.MCX.

ISKJ.MCX Daily Candlestick Chart
CHKZ.MCX
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CHKZ.MCX.

CHKZ.MCX Daily Candlestick Chart
VSYD.MCX
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VSYD.MCX.

VSYD.MCX Daily Candlestick Chart
VRSB.MCX
5 hours ago

I found you a Golden Cross on the daily chart of VRSB.MCX.

VRSB.MCX Daily Candlestick Chart
TBRU.MCX
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TBRU.MCX.

TBRU.MCX Daily Candlestick Chart
SNGSP.MCX
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SNGSP.MCX.

SNGSP.MCX Daily Candlestick Chart
RBCM.MCX
6 hours ago

I found you a Golden Cross on the daily chart of RBCM.MCX.

RBCM.MCX Daily Candlestick Chart
OKEY.MCX
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of OKEY.MCX.

OKEY.MCX Daily Candlestick Chart
MTLR.MCX
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MTLR.MCX.

MTLR.MCX Daily Candlestick Chart
MRKZ.MCX
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MRKZ.MCX.

MRKZ.MCX Daily Candlestick Chart
KRKN.MCX
6 hours ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of KRKN.MCX.

KRKN.MCX Daily Candlestick Chart
JNOS.MCX
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of JNOS.MCX.

JNOS.MCX Daily Candlestick Chart
BLNG.MCX
6 hours ago

I found you a Golden Cross on the daily chart of BLNG.MCX.

BLNG.MCX Daily Candlestick Chart
ASSB.MCX
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ASSB.MCX.

ASSB.MCX Daily Candlestick Chart
CSYZ.MU
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CSYZ.MU.

CSYZ.MU Daily Candlestick Chart
MOH.MU
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MOH.MU.

MOH.MU Daily Candlestick Chart
TBK.V
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TBK.V.

TBK.V Daily Candlestick Chart
UMDK.F
6 hours ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of UMDK.F.

UMDK.F Daily Candlestick Chart
RY4C.BE
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of RY4C.BE.

RY4C.BE Daily Candlestick Chart
PLY.BE
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of PLY.BE.

PLY.BE Daily Candlestick Chart
PDL.LSE
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of PDL.LSE.

PDL.LSE Daily Candlestick Chart
27F0.MU
6 hours ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of 27F0.MU.

27F0.MU Daily Candlestick Chart